167 related articles for article (PubMed ID: 38270146)
1. Multicenter Retrospective Study of Invasive Fusariosis in Intensive Care Units, France.
Demonchy J; Biard L; Clere-Jehl R; Wallet F; Mokart D; Moreau AS; Argaud L; Verlhac C; Pène F; Lautrette A; Bige N; de Jong A; Canet E; Quenot JP; Issa N; Zerbib Y; Bouard I; Picard M; Zafrani L
Emerg Infect Dis; 2024 Feb; 30(2):215-24. PubMed ID: 38270146
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and outcomes of invasive and non-invasive fusariosis in South Korea.
Park H; Bae S; Kim MJ; Chong YP; Kim SH; Choi SH; Lee SO; Kim YS; Jung J
Mycoses; 2023 Mar; 66(3):211-218. PubMed ID: 36349480
[TBL] [Abstract][Full Text] [Related]
3. Disseminated fusariosis and hematologic malignancies, a still devastating association. Report of three new cases.
García-Ruiz JC; Olazábal I; Adán Pedroso RM; López-Soria L; Velasco-Benito V; Sánchez-Aparicio JA; Navajas A; Montejo M; Moragues MD
Rev Iberoam Micol; 2015; 32(3):190-6. PubMed ID: 25936697
[TBL] [Abstract][Full Text] [Related]
4. Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009.
Campo M; Lewis RE; Kontoyiannis DP
J Infect; 2010 May; 60(5):331-7. PubMed ID: 20138081
[TBL] [Abstract][Full Text] [Related]
5. Invasive Fusariosis in Nonneutropenic Patients, Spain, 2000-2015.
Pérez-Nadales E; Alastruey-Izquierdo A; Linares-Sicilia MJ; Soto-Debrán JC; Abdala E; García-Rodríguez J; Montejo M; Muñoz P; Lletí MS; Rezusta A; de Pipaón MRP; Yáñez L; Merino E; Campos-Herrero MI; Costa-Mateo JM; Fortún J; García-Lozano T; Garcia-Vidal C; Fernández-Ruiz M; Sánchez-Reus F; Castro-Méndez C; Guerrero-Lozano I; Soler-Palacín P; Aguado JM; Martínez-Martínez L; Torre-Cisneros J; Nucci M;
Emerg Infect Dis; 2021 Jan; 27(1):26-35. PubMed ID: 33352085
[TBL] [Abstract][Full Text] [Related]
6. Fusariosis in Mexico: A 10-year retrospective series.
Barragán-Reyes A; Jácome LEL; Perales-Martínez D; Nava-Ruiz A; Hernández MLG; Cornejo-Juárez P; Rincón-Zuno J; Camacho A; Cendejas RF; Guzmán JMF; Rivera-Martínez NE; Ontañón-Zurita D; Reséndiz-Sánchez J; Juárez-Hernández E; Aguilar-Zapata D
Med Mycol; 2023 Dec; 61(12):. PubMed ID: 37944000
[TBL] [Abstract][Full Text] [Related]
7. Antimold Prophylaxis May Reduce the Risk of Invasive Fusariosis in Hematologic Patients with Superficial Skin Lesions with Positive Culture for Fusarium.
Varon AG; Nouér SA; Barreiros G; Trope BM; Akiti T; Nucci M
Antimicrob Agents Chemother; 2016 Dec; 60(12):7290-7294. PubMed ID: 27671065
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological aspects and characterization of the resistance profile of
Rosa PDD; Ramirez-Castrillon M; Borges R; Aquino V; Meneghello Fuentefria A; Zubaran Goldani L
J Med Microbiol; 2019 Oct; 68(10):1489-1496. PubMed ID: 31419209
[No Abstract] [Full Text] [Related]
9. Clinical features and outcomes in patients with disseminated toxoplasmosis admitted to intensive care: a multicenter study.
Schmidt M; Sonneville R; Schnell D; Bigé N; Hamidfar R; Mongardon N; Castelain V; Razazi K; Marty A; Vincent F; Dres M; Gaudry S; Luyt CE; Das V; Micol JB; Demoule A; Mayaux J
Clin Infect Dis; 2013 Dec; 57(11):1535-41. PubMed ID: 23994819
[TBL] [Abstract][Full Text] [Related]
10. Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance(®) registry.
Horn DL; Freifeld AG; Schuster MG; Azie NE; Franks B; Kauffman CA
Mycoses; 2014 Nov; 57(11):652-8. PubMed ID: 24943384
[TBL] [Abstract][Full Text] [Related]
11. Fusariosis.
Nucci F; Nouér SA; Capone D; Anaissie E; Nucci M
Semin Respir Crit Care Med; 2015 Oct; 36(5):706-14. PubMed ID: 26398537
[TBL] [Abstract][Full Text] [Related]
12. Clinical Features and Outcomes of Invasive Fusariosis: A Case Series in a Single Center with Literature Review.
Kim JY; Kang CI; Lee JH; Lee WJ; Huh K; Cho SY; Chung DR; Peck KR
Infect Chemother; 2023 Jun; 55(2):290-294. PubMed ID: 34227751
[No Abstract] [Full Text] [Related]
13. Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium--a groupe de recherche respiratoire en réanimation onco-hématologique study.
Azoulay E; Mokart D; Pène F; Lambert J; Kouatchet A; Mayaux J; Vincent F; Nyunga M; Bruneel F; Laisne LM; Rabbat A; Lebert C; Perez P; Chaize M; Renault A; Meert AP; Benoit D; Hamidfar R; Jourdain M; Darmon M; Schlemmer B; Chevret S; Lemiale V
J Clin Oncol; 2013 Aug; 31(22):2810-8. PubMed ID: 23752112
[TBL] [Abstract][Full Text] [Related]
14. How different is invasive fusariosis in pediatric patients than in adults? A systematic review.
Rossato L; Carlesse F; Nobrega de Almeida J; Kontoyiannis DP; Colombo AL
Curr Opin Infect Dis; 2021 Dec; 34(6):619-626. PubMed ID: 34751181
[TBL] [Abstract][Full Text] [Related]
15. Refractory disseminated fusariosis by Fusarium verticillioides in a patient with acute myeloid leukaemia relapsed after allogeneic hematopoietic stem cell transplantation: a case report and literature review.
Fanci R; Pini G; Bartolesi AM; Pecile P
Rev Iberoam Micol; 2013 Jan; 30(1):51-3. PubMed ID: 22659590
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Fusarium Infection of the Central Nervous System: A Review of Past Cases to Guide Therapy for the Ongoing 2023 Outbreak in the United States and Mexico.
Hoenigl M; Jenks JD; Egger M; Nucci M; Thompson GR
Mycopathologia; 2023 Dec; 188(6):973-981. PubMed ID: 37653167
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival after cord blood transplantation for acute myeloid leukemia complicated with disseminated fusariosis.
Ichikawa S; Fukuhara N; Watanabe S; Okitsu Y; Onodera K; Onishi Y; Harigae H
J Infect Chemother; 2020 Feb; 26(2):292-295. PubMed ID: 31570321
[TBL] [Abstract][Full Text] [Related]
18. A retrospective cohort of invasive fusariosis in the era of antimould prophylaxis.
Fernández-Cruz A; Semiglia MA; Guinea J; Martínez-Jiménez MDC; Escribano P; Kwon M; Rodríguez-Macías G; Chamorro-de-Vega E; Rodríguez-González C; Navarro R; Galar A; Sánchez-Carrillo C; Díez-Martín JL; Muñoz P
Med Mycol; 2020 Apr; 58(3):300-309. PubMed ID: 31231772
[TBL] [Abstract][Full Text] [Related]
19. Hematologic malignancies in the medical intensive care unit--Outcomes and prognostic factors.
Grgić Medić M; Gornik I; Gašparović V
Hematology; 2015 Jun; 20(5):247-53. PubMed ID: 25310461
[TBL] [Abstract][Full Text] [Related]
20. Acute Respiratory Failure Outcomes in Patients with Hematologic Malignancies and Hematopoietic Cell Transplant: A Secondary Analysis of the EFRAIM Study.
Munshi L; Darmon M; Soares M; Pickkers P; Bauer P; Meert AP; Martin-Loeches I; Staudinger T; Pene F; Antonelli M; Barratt-Due A; Demoule A; Metaxa V; Lemiale V; Taccone F; Mokart D; Azoulay E; Mehta S;
Transplant Cell Ther; 2021 Jan; 27(1):78.e1-78.e6. PubMed ID: 33011289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
